New York Presbyterian Hospital/Weill Cornell Medical Center is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Hospital/Weill Cornell Medical Center has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: Metastatic Pancreatic Cancer, Pancreatic Cancer, Peripheral Artery Disease.
Sponsors: Gilead Sciences, W.L.Gore & Associates, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Hospital/Weill Cornell Medical Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Hospital/Weill Cornell Medical Center has 10 clinical trials on record, with 2 currently active. Their work covers Metastatic Pancreatic Cancer, Pancreatic Cancer, Peripheral Artery Disease.
Yes — New York Presbyterian Hospital/Weill Cornell Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.